|
Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
|
12/20/19
|
Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
|
PDF
|
|
Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark
|
12/20/19
|
Bausch Health Announces Resolution Of BRYHALI® (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark
|
PDF
|
|
FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris
|
12/19/19
|
FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris
|
PDF
|
|
Bausch Health Announces Conditional Redemption Of Existing Senior Notes
|
12/18/19
|
Bausch Health Announces Conditional Redemption Of Existing Senior Notes
|
PDF
|
|
Bausch Health Announces Pricing of Private Offering of Senior Notes
|
12/17/19
|
Bausch Health Announces Pricing of Private Offering of Senior Notes
|
PDF
|
|
Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery
|
12/17/19
|
Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD) For Use In Cataract Surgery
|
PDF
|
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes
|
12/17/19
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes
|
PDF
|
|
Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015
|
12/16/19
|
Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015
|
PDF
|
|
Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology
|
12/11/19
|
Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex™ Technology
|
PDF
|
|
Bausch + Lomb And TerraCycle Announce Donation Of New Custom Training Modules Incorporating Used Contact Lens Materials To Guide Dog Foundation
|
11/13/19
|
Bausch + Lomb And TerraCycle Announce Donation Of New Custom Training Modules Incorporating Used Contact Lens Materials To Guide Dog Foundation
|
PDF
|
|
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
|
11/11/19
|
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
|
PDF
|
|
Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges
|
11/04/19
|
Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges
|
pdf
|
|
Salix Announces Issuance of an Additional XIFAXAN® Patent
|
10/31/19
|
Salix Announces Issuance of an Additional XIFAXAN® Patent
|
PDF
|
|
Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary
|
10/30/19
|
Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary
|
PDF
|
|
Salix Pharmaceuticals to Present New Clinical Data at the American College of Gastroenterology (ACG) Annual Meeting
|
10/28/19
|
Salix Pharmaceuticals to Present New Clinical Data at the American College of Gastroenterology (ACG) Annual Meeting
|
PDF
|
|
Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
|
10/23/19
|
Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
|
PDF
|
|
Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins
|
10/21/19
|
Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins
|
PDF
|
|
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
|
10/15/19
|
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
|
PDF
|
|
Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients
|
10/10/19
|
Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients
|
PDF
|
|
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings
|
10/07/19
|
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings
|
PDF
|
|
Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4
|
10/04/19
|
Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4
|
PDF
|
|
Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets
|
10/01/19
|
Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets
|
PDF
|
|
Bausch Health Releases 2018 Corporate Social Responsibility Report
|
09/10/19
|
Bausch Health Releases 2018 Corporate Social Responsibility Report
|
PDF
|
|
Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations
|
09/03/19
|
Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations
|
PDF
|
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
08/29/19
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
PDF
|
|
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form
|
08/07/19
|
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form
|
PDF
|
|
Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance
|
08/06/19
|
Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance
|
pdf
|
|
Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide
|
08/01/19
|
Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide
|
PDF
|
|
Bausch Health Provides APRISO® Intellectual Property Litigation Update
|
07/31/19
|
Bausch Health Provides APRISO® Intellectual Property Litigation Update
|
PDF
|
|
Bausch Health to Reduce Debt by Additional $100 Million Using Cash Flow from Operations
|
07/29/19
|
Bausch Health to Reduce Debt by Additional $100 Million Using Cash Flow from Operations
|
PDF
|
|
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets
|
07/17/19
|
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets
|
PDF
|
|
Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins
|
07/09/19
|
Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins
|
PDF
|
|
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6
|
07/08/19
|
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6
|
PDF
|
|
Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations
|
06/25/19
|
Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations
|
PDF
|
|
Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults
|
06/25/19
|
Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults
|
PDF
|
|
Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States
|
06/19/19
|
Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States
|
PDF
|
|
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
|
05/29/19
|
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
|
PDF
|
|
Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes
|
05/23/19
|
Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes
|
PDF
|
|
Bausch Health Announces Pricing Of Private Offering Of Senior Notes
|
05/09/19
|
Bausch Health Announces Pricing Of Private Offering Of Senior Notes
|
PDF
|
|
Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series
|
05/09/19
|
Bausch Health Commences Cash Tender Offers For Up To $1,500,000,000 Aggregate Principal Amount Of Outstanding Notes Of Certain Series
|
PDF
|
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes
|
05/09/19
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes
|
PDF
|
|
Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance
|
05/06/19
|
Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance
|
pdf
|
|
Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation
|
04/30/19
|
Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation
|
PDF
|
|
Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During The Annual Meeting Of The American Society Of Cataract And Refractive Surgery
|
04/29/19
|
Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During The Annual Meeting Of The American Society Of Cataract And Refractive Surgery
|
PDF
|
|
New Scientific And Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting
|
04/26/19
|
New Scientific And Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting
|
PDF
|
|
FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults
|
04/25/19
|
FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults
|
PDF
|
|
Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease
|
04/25/19
|
Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease
|
PDF
|
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
04/24/19
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
PDF
|
|
Bausch + Lomb Reports More Than 9.2 Million Units Of Contact Lens Materials Diverted From Waste Stream Through ONE By ONE Recycling Program
|
04/22/19
|
Bausch + Lomb Reports More Than 9.2 Million Units Of Contact Lens Materials Diverted From Waste Stream Through ONE By ONE Recycling Program
|
PDF
|
|
Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6
|
04/08/19
|
Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6
|
PDF
|
|
Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery
|
04/02/19
|
Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery
|
PDF
|
|
Salix Enters Into License Agreement With The University Of California To Develop And Commercialize Novel Compound For The Treatment Of Non-alcoholic Fatty Liver Disease And Non-alcoholic Steatohepatitis
|
04/01/19
|
Salix Enters Into License Agreement With The University Of California To Develop And Commercialize Novel Compound For The Treatment Of Non-alcoholic Fatty Liver Disease And Non-alcoholic Steatohepatitis
|
PDF
|
|
Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions
|
03/11/19
|
Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions
|
PDF
|
|
Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes
|
03/08/19
|
Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes
|
PDF
|
|
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes
|
03/08/19
|
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes
|
PDF
|
|
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
|
03/06/19
|
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
|
PDF
|
|
Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting
|
02/28/19
|
Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting
|
PDF
|
|
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
|
02/26/19
|
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
|
PDF
|
|
Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery
|
02/25/19
|
Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery
|
PDF
|
|
Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price
|
02/22/19
|
Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price
|
PDF
|
|
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes
|
02/22/19
|
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes
|
PDF
|
|
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes
|
02/22/19
|
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes
|
PDF
|
|
Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price
|
02/22/19
|
Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price
|
PDF
|
|
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
|
02/20/19
|
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
|
pdf
|
|
Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies
|
02/19/19
|
Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies
|
PDF
|
|
Bausch Health Provides Update For DUOBRII Filing
|
02/15/19
|
Bausch Health Provides Update For DUOBRII Filing
|
PDF
|
|
Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Lens Materials And Zenlens™ Family Of Scleral Lenses
|
02/13/19
|
Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Lens Materials And Zenlens™ Family Of Scleral Lenses
|
PDF
|
|
Bausch + Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition
|
02/04/19
|
Bausch + Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition
|
PDF
|
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
02/01/19
|
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
|
PDF
|
|
Bausch Health Reduces Debt By Additional $100 Million
|
01/29/19
|
Bausch Health Reduces Debt By Additional $100 Million
|
PDF
|
|
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20
|
01/18/19
|
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20
|
PDF
|
|
Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference
|
01/07/19
|
Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference
|
PDF
|
|
Bausch Health To Present At The 37th Annual J.P. Morgan Healthcare Conference
|
01/02/19
|
Bausch Health To Present At The 37th Annual J.P. Morgan Healthcare Conference
|
PDF
|
